Giant Axonal Neuropathy (GAN) Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Giant Axonal Neuropathy (GAN) Market is segmented By Treatment (Gene Therapy, Enzyme Replacement Therapy, Supportive Care), By Distribution Channel (Hospitals, Specialty Clinics, Online Pharmacies), By Age Group (Pediatric, Adult), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Million) for the above-mentioned segments.

Giant Axonal Neuropathy (GAN) Market is segmented By Treatment (Gene Therapy, Enzyme Replacement Therapy, Supportive Care), By Distribution Channel (H....

Giant Axonal Neuropathy (GAN) Market Size

Market Size in USD

CAGR5.5%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	5.5%
Market Concentration	High
Major Players	Applied Genetic Technologies Corporation (AGTC), Audentes Therapeutics (acquired by Astellas Pharma), Passage Bio, Voyager Therapeutics, Neuron Biopharma

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Giant Axonal Neuropathy (GAN) Market Analysis

The giant axonal neuropathy (GAN) Market is estimated to be valued at USD 119.6 Mn in 2024 and is expected to reach USD 174.4 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031. Enhanced research activities for development of novel treatment therapies have boosted growth prospects for the giant axonal neuropathy (GAN) market.

Giant Axonal Neuropathy (GAN) Market Report Snapshots

Buy Now